Scientific Support


Scientific Support & Reference Citations References


  2. Anthony C Pyrroloquinoline quinone (PQQ) and quinoprotein enzymesAntioxid Redox Signal. (2001)
  3. Kumazawa T1, et al Levels of pyrroloquinoline quinone in various foodsBiochem J. (1995)
  4. Noji N, et al Simple and sensitive method for pyrroloquinoline quinone (PQQ) analysis in various foods using liquid chromatography/electrospray-ionization tandem mass spectrometryJ Agric Food Chem. (2007)
  5. Mitchell AE, et al Characterization of pyrroloquinoline quinone amino acid derivatives by electrospray ionization mass spectrometry and detection in human milkAnal Biochem. (1999)
  6. Mitchell AE, et al Characterization of Pyrroloquinoline Quinone Amino Acid Derivatives by Electrospray Ionization Mass Spectrometry and Detection in Human MilkAnal Biochem. (1999)
  7. Steinberg F, et al Pyrroloquinoline quinone improves growth and reproductive performance in mice fed chemically defined dietsExp Biol Med (Maywood). (2003)
  8. Ikemoto K, Sakamoto H, Nakano M Crystal structure and characterization of pyrroloquinoline quinone disodium trihydrateChem Cent J. (2012)
  9. Ishida T, et al Molecular and crystal structure of PQQ (methoxatin), a novel coenzyme of quinoproteins: extensive stacking character and metal ion interactionJ Am Chem Soc. (1989)
  10. Rucker R, Chowanadisai W, Nakano M Potential physiological importance of pyrroloquinoline quinoneAltern Med Rev. (2009)
  11. Kim J, et al Pyrroloquinoline quinone inhibits the fibrillation of amyloid proteinsPrion. (2010)
  12. Mukai K, Ouchi A, Nakano M Kinetic study of the quenching reaction of singlet oxygen by Pyrroloquinolinequinol (PQQH(2), a reduced form of Pyrroloquinolinequinone) in micellar solutionJ Agric Food Chem. (2011)
  13. Yoshida W, et al Partial peptide of α-synuclein modified with small-molecule inhibitors specifically inhibits amyloid fibrillation of α-synucleinInt J Mol Sci. (2013)
  14. Adachi O, et al Adduct formation of pyrroloquinoline quinone and amino acidBiofactors. (1988)
  15. Zhang Y, Rosenberg PA The essential nutrient pyrroloquinoline quinone may act as a neuroprotectant by suppressing peroxynitrite formationEur J Neurosci. (2002)
  16. Kasahara T, Kato T Nutritional biochemistry: A new redox-cofactor vitamin for mammalsNature. (2003)
  17. Felton LM, Anthony C Biochemistry: role of PQQ as a mammalian enzyme cofactorNature. (2005)
  18. Rucker R, et al Biochemistry: is pyrroloquinoline quinone a vitaminNature. (2005)
  19. Wang L, et al Cloning and characterization of a novel human homolog* of mouse U26, a putative PQQ-dependent AAS dehydrogenaseMol Biol Rep. (2005)
  20. Bauerly KA, et al Pyrroloquinoline quinone nutritional status alters lysine metabolism and modulates mitochondrial DNA content in the mouse and ratBiochim Biophys Acta. (2006)
  21. Stites TE, Mitchell AE, Rucker RB Physiological importance of quinoenzymes and the O-quinone family of cofactorsJ Nutr. (2000)
  22. Goodwin PM, Anthony C The Biochemistry, Physiology and Genetics of PQQ and PQQ-containing EnzymesAdv Microb Physiol. (1998)
  23. Puehringer S, Metlitzky M, Schwarzenbacher R The pyrroloquinoline quinone biosynthesis pathway revisited: a structural approachBMC Biochem. (2008)
  24. Flückiger R, et al Characterization of the glycine-dependent redox-cycling activity in animal fluids and tissues using specific inhibitors and activators: evidence for presence of PQQBiochem Biophys Res Commun. (1993)
  25. Flückiger R, Paz MA, Gallop PM Redox-cycling detection of dialyzable pyrroloquinoline quinone and quinoproteinsMethods Enzymol. (1995)
  26. Stites T, et al Pyrroloquinoline quinone modulates mitochondrial quantity and function in miceJ Nutr. (2006)
  27. Bauerly K, et al Altering pyrroloquinoline quinone nutritional status modulates mitochondrial, lipid, and energy metabolism in ratsPLoS One. (2011)
  28. Harris CB, et al Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjectsJ Nutr Biochem. (2013)
  29. Paz MA, et al The catalysis of redox cycling by pyrroloquinoline quinone (PQQ), PQQ derivatives, and isomers and the specificity of inhibitorsAnal Biochem. (1996)
  30. Paz MA, et al Specific detection of quinoproteins by redox-cycling stainingJ Biol Chem. (1991)
  31. Salisbury SA, et al A novel coenzyme from bacterial primary alcohol dehydrogenaseNature. (1979)
  32. Dooley DM, et al The generation of an organic free radical in substrate-reduced pig kidney diamine oxidase-cyanideFEBS Lett. (1987)
  33. van der Meer RA, et al Primary structure of a pyrroloquinoline quinone (PQQ) containing peptide isolated from porcine kidney diamine oxidaseBiochem Biophys Res Commun. (1989)
  34. Groen BW, van der Meer RA, Duine JA Evidence for PQQ as cofactor in 3,4-dihydroxyphenylalanine (dopa) decarboxylase of pig kidneyFEBS Lett. (1988)
  35. van der Meer RA, Jongejan JA, Duine JA Dopamine beta-hydroxylase from bovine adrenal medulla contains covalently-bound pyrroloquinoline quinoneFEBS Lett. (1988)
  36. Robertson JG, et al Spectral studies of bovine dopamine beta-hydroxylase. Absence of covalently bound pyrroloquinoline quinoneJ Biol Chem. (1989)
  37. Duine JA PQQ in plants (and animals)Trends Biochem Sci. (1991)
  38. Klinman JP, et al Status of the cofactor identity in copper oxidative enzymesFEBS Lett. (1991)
  39. Kamata H, Hirata H Redox regulation of cellular signallingCell Signal. (1999)
  40. Ouchi A1, et al Kinetic study of the antioxidant activity of pyrroloquinolinequinol (PQQH(2), a reduced form of pyrroloquinolinequinone) in micellar solutionJ Agric Food Chem. (2009)
  41. Kimura K, et al Pyrroloquinoline quinone stimulates epithelial cell proliferation by activating epidermal growth factor receptor through redox cyclingFree Radic Biol Med. (2012)
  42. Takada M, et al Pyrroloquinoline quinone, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves impaired glucose tolerance in diabetic KK-A(y) miceBiochem Biophys Res Commun. (2012)
  43. Arnér ES, Holmgren A Physiological functions of thioredoxin and thioredoxin reductaseEur J Biochem. (2000)
  44. Xu J, Arnér ES Pyrroloquinoline quinone modulates the kinetic parameters of the mammalian selenoprotein thioredoxin reductase 1 and is an inhibitor of glutathione reductaseBiochem Pharmacol. (2012)
  45. Cenas N, et al Interactions of nitroaromatic compounds with the mammalian selenoprotein thioredoxin reductase and the relation to induction of apoptosis in human cancer cellsJ Biol Chem. (2006)
  46. Brigelius-Flohé R, et al The yin and yang of nrf2-regulated selenoproteins in carcinogenesisInt J Cell Biol. (2012)
  47. Locy ML, et al Thioredoxin reductase inhibition elicits nrf2-mediated responses in clara cells: implications for oxidant-induced lung injuryAntioxid Redox Signal. (2012)
  48. Suvorova ES, et al Cytoprotective Nrf2 pathway is induced in chronically txnrd 1-deficient hepatocytesPLoS One. (2009)
  49. Tchaparian E, et al Identification of transcriptional networks responding to pyrroloquinoline quinone dietary supplementation and their influence on thioredoxin expression, and the JAK/STAT and MAPK pathwaysBiochem J. (2010)
  50. Puigserver P Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alphaInt J Obes (Lond). (2005)
  51. Chowanadisai W, et al Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expressionJ Biol Chem. (2010)
  52. Steinberg FM, Gershwin ME, Rucker RB Dietary pyrroloquinoline quinone: growth and immune response in BALB/c miceJ Nutr. (1994)
  53. Wasserman K, et al Lactate, pyruvate, and lactate-to-pyruvate ratio during exercise and recoveryJ Appl Physiol (1985). (1985)
  54. Guan M, et al Systemic perturbations of key metabolites in diabetic rats during the evolution of diabetes studied by urine metabonomicsPLoS One. (2013)
  55. Terán-García M, Ibarra I, Velázquez A Urinary organic acids in infant malnutritionPediatr Res. (1998)
  56. Kumazawa T, et al Activation of Ras signaling pathways by pyrroloquinoline quinone in NIH3T3 mouse fibroblastsInt J Mol Med. (2007)
  57. Ishii T, et al Pro-oxidant action of pyrroloquinoline quinone: characterization of protein oxidative modificationsBiosci Biotechnol Biochem. (2010)
  58. Lee SR, et al Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factorJ Biol Chem. (1998)
  59. Rhee SG, et al Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidationSci STKE. (2000)
  60. Huyer G, et al Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadateJ Biol Chem. (1997)
  61. Goldstein BJ Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistanceCurr Drug Targets Immune Endocr Metabol Disord. (2001)
  62. Cantó C, Auwerx J Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)?Pharmacol Rev. (2012)
  63. Boutant M, Cantó C SIRT1 metabolic actions: Integrating recent advances from mouse modelsMol Metab. (2013)
  64. Li X SIRT1 and energy metabolismActa Biochim Biophys Sin (Shanghai). (2013)
  65. Herranz D, et al Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancerNat Commun. (2010)
  66. Banks AS, et al SirT1 gain of function increases energy efficiency and prevents diabetes in miceCell Metab. (2008)
  67. Pfluger PT, et al Sirt1 protects against high-fat diet-induced metabolic damageProc Natl Acad Sci U S A. (2008)
  68. Kendrick AA, et al Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylationBiochem J. (2011)
  69. Brenmoehl J, Hoeflich A Dual control of mitochondrial biogenesis by sirtuin 1 and sirtuin 3Mitochondrion. (2013)
  70. Smidt CR, et al Intestinal absorption and tissue distribution of {14C}pyrroloquinoline quinone in miceProc Soc Exp Biol Med. (1991)
  71. VanEngelen MR, et al Uranium exerts acute toxicity by binding to pyrroloquinoline quinone cofactorEnviron Sci Technol. (2011)
  72. Schürer G Is the calcium-ion catalysis of biological reoxidation of reduced PQQ purely electrostatic?Chem Commun. (1998)
  73. Zheng YJ, Bruice TC Conformation of coenzyme pyrroloquinoline quinone and role of Ca2+ in the catalytic mechanism of quinoprotein methanol dehydrogenaseProc Natl Acad Sci U S A. (1997)
  74. Aizenman E, Hartnett KA, Reynolds IJ Oxygen free radicals regulate NMDA receptor function via a redox modulatory siteNeuron. (1990)
  75. Aizenman E, Lipton SA, Loring RH Selective modulation of NMDA responses by reduction and oxidationNeuron. (1989)
  76. Tang LH, Aizenman E The modulation of N-methyl-D-aspartate receptors by redox and alkylating reagents in rat cortical neurones in vitroJ Physiol. (1993)
  77. Aizenman E, et al Further evidence that pyrroloquinoline quinone interacts with the N-methyl-D-aspartate receptor redox site in rat cortical neurons in vitroNeurosci Lett. (1994)
  78. Aizenman E, et al Interaction of the putative essential nutrient pyrroloquinoline quinone with the N-methyl-D-aspartate receptor redox modulatory siteJ Neurosci. (1992)
  79. Scanlon JM, Aizenman E, Reynolds IJ Effects of pyrroloquinoline quinone on glutamate-induced production of reactive oxygen species in neuronsEur J Pharmacol. (1997)
  80. Zhang Q, et al Pyrroloquinoline quinone rescues hippocampal neurons from glutamate-induced cell death through activation of Nrf2 and up-regulation of antioxidant genesGenet Mol Res. (2012)
  81. Zhang Q, et al Pyrroloquinoline quinine protects rat brain cortex against acute glutamate-induced neurotoxicityNeurochem Res. (2013)
  82. Zhang Q, et al The neuroprotective action of pyrroloquinoline quinone against glutamate-induced apoptosis in hippocampal neurons is mediated through the activation of PI3K/Akt pathwayToxicol Appl Pharmacol. (2011)
  83. Panov A, et al Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxicationJ Biol Chem. (2005)
  84. Sherer TB, et al Mechanism of toxicity in rotenone models of Parkinson’s diseaseJ Neurosci. (2003)
  85. Qin J, et al Pyrroloquinoline quinone-conferred neuroprotection in rotenone models of Parkinson’s diseaseToxicol Lett. (2015)
  86. Yamaguchi K, et al Stimulation of nerve growth factor production by pyrroloquinoline quinone and its derivatives in vitro and in vivoBiosci Biotechnol Biochem. (1993)
  87. Urakami T, et al Synthesis of esters of coenzyme PQQ and IPQ, and stimulation of nerve growth factor productionBiofactors. (1995-1996)
  88. Yamaguchi K, et al Cyclooxygenase induction is essential for NGF synthesis enhancement by NGF inducers in L-M cellsBiosci Biotechnol Biochem. (1996)
  89. He B, Liu SQ, Li HH The roles of PI3K/Akt pathway in proliferation of Schwann cells promoted by pyrroloquinoline quinoneZhonghua Zheng Xing Wai Ke Za Zhi. (2010)
  90. Hatanaka M, et al 15d-prostaglandin J2 enhancement of nerve growth factor-induced neurite outgrowth is blocked by the chemoattractant receptor- homologous molecule expressed on T-helper type 2 cells (CRTH2) antagonist CAY10471 in PC12 cellsJ Pharmacol Sci. (2010)
  91. Bulló M, Peeraully MR, Trayhurn P Stimulation of NGF expression and secretion in 3T3-L1 adipocytes by prostaglandins PGD2, PGJ2, and Delta12-PGJ2Am J Physiol Endocrinol Metab. (2005)
  92. Toyomoto M, et al Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte culturesFEBS Lett. (2004)
  93. Satoh T, et al Prostaglandin J2 and its metabolites promote neurite outgrowth induced by nerve growth factor in PC12 cellsBiochem Biophys Res Commun. (1999)
  94. Murase K, et al Stimulation of nerve growth factor synthesis/secretion in mouse astroglial cells by coenzymesBiochem Mol Biol Int. (1993)
  95. Liu S, et al Enhanced rat sciatic nerve regeneration through silicon tubes filled with pyrroloquinoline quinoneMicrosurgery. (2005)
  96. Satake K, et al Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injuryBrain Res Mol Brain Res. (2000)
  97. Xu J, et al iNOS and nitrotyrosine expression after spinal cord injuryJ Neurotrauma. (2001)
  98. Hirakawa A, et al Pyrroloquinoline quinone attenuates iNOS gene expression in the injured spinal cordBiochem Biophys Res Commun. (2009)
  99. Gong D, et al Effect of pyrroloquinoline quinone on neuropathic pain following chronic constriction injury of the sciatic nerve in ratsEur J Pharmacol. (2012)
  100. Zhang Y, Rosenberg PA The essential nutrient pyrroloquinoline quinone may act as a neuroprotectant by suppressing peroxynitrite formationEur J Neurosci. (2002)
  101. Urakami T, et al Synthesis of monoesters of pyrroloquinoline quinone and imidazopyrroloquinoline, and radical scavenging activities using electron spin resonance in vitro and pharmacological activity in vivoJ Nutr Sci Vitaminol (Tokyo). (1997)
  102. Gallop PM, et al Is the antioxidant, anti-inflammatory putative new vitamin, PQQ, involved with nitric oxide in bone metabolismConnect Tissue Res. (1993)
  103. Chapman AG Glutamate receptors in epilepsyProg Brain Res. (1998)
  104. Bradford HF Glutamate, GABA and epilepsyProg Neurobiol. (1995)
  105. Sanchez RM, et al Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizuresJ Neurosci. (2000)
  106. Hoshi Y, Tamura M Dynamic changes in cerebral oxygenation in chemically induced seizures in rats: study by near-infrared spectrophotometryBrain Res. (1993)
  107. Fujikawa DG, et al Generalized seizures deplete brain energy reserves in normoxemic newborn monkeysBrain Res. (1988)
  108. Dannhardt G, Kohl BK The glycine site on the NMDA receptor: structure-activity relationships and possible therapeutic applicationsCurr Med Chem. (1998)
  109. Kornhuber J, Weller M Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapyBiol Psychiatry. (1997)
  110. Jensen FE, et al The putative essential nutrient pyrroloquinoline quinone is neuroprotective in a rodent model of hypoxic/ischemic brain injuryNeuroscience. (1994)
  111. Zhang Y, Feustel PJ, Kimelberg HK Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult ratBrain Res. (2006)
  112. Zhang L, et al The neuroprotective effect of pyrroloquinoline quinone on traumatic brain injuryJ Neurotrauma. (2012)
  113. Ohwada K, et al Pyrroloquinoline Quinone (PQQ) Prevents Cognitive Deficit Caused by Oxidative Stress in RatsJ Clin Biochem Nutr. (2008)
  114. Zhang P, et al Protection of pyrroloquinoline quinone against methylmercury-induced neurotoxicity via reducing oxidative stressFree Radic Res. (2009)
  115. Zhang P, et al In vitro protective effects of pyrroloquinoline quinone on methylmercury-induced neurotoxicityEnviron Toxicol Pharmacol. (2009)
  116. Takatsu H, et al Effect of vitamin E on learning and memory deficit in aged ratsJ Nutr Sci Vitaminol (Tokyo). (2009)
  117. Nakano M, et al Effect of Pyrroloquinoline Quinone (PQQ) on mental status of Middle-Aged and Elderly PersonsFood Style. (2009)
  118. Itoh Y, et al Effect of the Antioxidant Supplement Pyrroloquinoline Quinone Disodium Salt on Cognitive Functions . Adv Exp Med Biol. (2016)
  119. Nakano M, et al Effects of Oral Supplementation with Pyrroloquinoline Quinone on Stress, Fatigue, and SleepFunct Foods Health Dis. (2012)
  120. Zhu BQ, et al Pyrroloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusionCardiovasc Drugs Ther. (2004)
  121. Tao R, et al Pyrroloquinoline quinone preserves mitochondrial function and prevents oxidative injury in adult rat cardiac myocytesBiochem Biophys Res Commun. (2007)
  122. Zhu BQ, et al Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injuryJ Cardiovasc Pharmacol Ther. (2006)
  123. Singh SK, et al The connection between C-reactive protein and atherosclerosisAnn Med. (2008)
  124. Stella C, et al Susceptibility of human metabolic phenotypes to dietary modulationJ Proteome Res. (2006)
  125. Muoio DM, Koves TR Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic diseaseAppl Physiol Nutr Metab. (2007)
  126. Odkhuu E, et al Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ)Immunol Lett. (2012)
  127. Zhao Q, et al NFATc1: functions in osteoclastsInt J Biochem Cell Biol. (2010)
  128. Takayanagi H, et al Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclastsDev Cell. (2002)
  129. Ikeda F, et al Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiationJ Clin Invest. (2004)
  130. Wagner EF, Eferl R Fos/AP-1 proteins in bone and the immune systemImmunol Rev. (2005)
  131. Abraham AK, et al Mechanisms of interferon-beta effects on bone homeostasisBiochem Pharmacol. (2009)
  132. Takayanagi H, et al RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-betaNature. (2002)
  133. Takayanagi H, et al Interplay between interferon and other cytokine systems in bone metabolismImmunol Rev. (2005)
  134. Tremblay F, et al Role of dietary proteins and amino acids in the pathogenesis of insulin resistanceAnnu Rev Nutr. (2007)
  135. Omata J, et al Influence of adding pyrroloquinoline quinone to parenteral nutrition on gut-associated lymphoid tissueJPEN J Parenter Enteral Nutr. (2011)
  136. Hogg N1, et al Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxideBiochem J. (1992)
  137. Rein D, et al Epicatechin in human plasma: in vivo determination and effect of chocolate consumption on plasma oxidation statusJ Nutr. (2000)
  138. Xiong XH, et al Production and radioprotective effects of pyrroloquinoline quinoneInt J Mol Sci. (2011)
  139. Tsuchida T, et al The protective effect of pyrroloquinoline quinone and its derivatives against carbon tetrachloride-induced liver injury of ratsJ Gastroenterol Hepatol. (1993)
  140. Adachi O, et al New developments in oxidative fermentationAppl Microbiol Biotechnol. (2003)
  141. Matsushita K, et al Escherichia coli is unable to produce pyrroloquinoline quinone (PQQ)Microbiology. (1997)
  142. Smidt CR, et al Does the intestinal microflora synthesize pyrroloquinoline quinoneBiofactors. (1991)
  143. Shankar BS, et al Role of glutathione in augmenting the anticancer activity of pyrroloquinoline quinone (PQQ)Redox Rep. (2010)
  144. He K, et al Antioxidant and pro-oxidant properties of pyrroloquinoline quinone (PQQ): implications for its function in biological systemsBiochem Pharmacol. (2003)
  145. Sato K, Toriyama M Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanomaJ Dermatol Sci. (2009)
  146. Kosano H, et al Pyrroloquinoline quinone (PQQ) inhibits the expression of tyrosinase mRNA by alpha-melanocyte stimulating hormone in murine B16 melanoma cellsLife Sci. (1995)
  147. Irizarry MC, et al Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson’s disease and cortical Lewy body disease contain alpha-synuclein immunoreactivityJ Neuropathol Exp Neurol. (1998)
  148. Wakabayashi K, et al NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson’s diseaseNeurosci Lett. (1997)
  149. Spillantini MG, et al Alpha-synuclein in Lewy bodiesNature. (1997)
  150. Sode K, et al Engineered alpha-synuclein prevents wild type and familial Parkin variant fibril formationBiochem Biophys Res Commun. (2005)
  151. Moussa CE, et al Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamineBiochemistry. (2004)
  152. Kim TD, Paik SR, Yang CH Structural and functional implications of C-terminal regions of alpha-synucleinBiochemistry. (2002)
  153. Zhu M, et al The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrilsJ Biol Chem. (2004)
  154. Kim J, et al The inhibitory effect of pyrroloquinoline quinone on the amyloid formation and cytotoxicity of truncated alpha-synucleinMol Neurodegener. (2010)
  155. Liu CW, et al A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson diseaseJ Biol Chem. (2005)
  156. Andrew R, et al The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controlsNeurochem Res. (1993)
  157. Hara H, Hiramatsu H, Adachi T Pyrroloquinoline quinone is a potent neuroprotective nutrient against 6-hydroxydopamine-induced neurotoxicityNeurochem Res. (2007)
  158. Yokota T, et al Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibitionBiochem Biophys Res Commun. (2003)
  159. Lev N, et al Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotectionNeurotoxicology. (2008)
  160. Bonifati V, et al Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonismScience. (2003)
  161. Nunome K, et al Pyrroloquinoline quinone prevents oxidative stress-induced neuronal death probably through changes in oxidative status of DJ-1Biol Pharm Bull. (2008)
  162. Zhou W, et al The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synucleinJ Mol Biol. (2006)
  163. Kobayashi M, et al Pyrroloquinoline quinone (PQQ) prevents fibril formation of alpha-synucleinBiochem Biophys Res Commun. (2006)
  164. Zhang JJ, Zhang RF, Meng XK Protective effect of pyrroloquinoline quinone against Abeta-induced neurotoxicity in human neuroblastoma SH-SY5Y cellsNeurosci Lett. (2009)
  165. Watanabe A, et al Nephrotoxicity of pyrroloquinoline quinone in ratsHiroshima J Med Sci. (1989)